Dialysis News: Breaking Dialysis News, Comments and Articles. - Page: 3

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

NEW YORK, May 7, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the first quarter ended March 31, 2013. At March 31, 2013, the Company had cash and cash...

Tuesday's most followed in U.S. including Fossil, Tesla, Baxter, Electronic Arts, First Solar, DirecTV and Dow Chemical

  U.S. shares fluctuated on Tuesday Morning.  The 30-member Dow Jones Industrial Average Index (INDEXDJX:.DJI) gained 0.3 percent to 15,005.62, whereas the Nasdaq Composite Index (INDEXNASDAQ:.IXIC) fell 0.2 percent to 3,387.7. Most followe...

AminoActiv® Lessens the Economic Burden of Diabetes, While Offering Equal or Better Pain Relief and Fewer Side Effects Than NSAIDs

MADISON, Tenn., May 7, 2013 /PRNewswire/ -- Since 2007, the total cost of diabetes treatment in the United States has risen from $174 billion to $245 billion. Nearly 26 million adults and children currently live with the disease. Per capita medical expenditures now total $7,900. Chronic pain and neuropathy necessitate a steady regimen of prescription pain relief medications, which is one of t...

RenalGuard Clinical Data Presented at International Conference of the Israel Heart Society

MILFORD, MA--(Marketwired - May 07, 2013) - PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that clinical results using RenalGuard Therapy® were reported by researchers from two Israeli hospitals at The 60th International Conference of the Israel Heart Society. Dr. Eyal Ben-Assa of Tel Aviv Medical Center presented a poster reporting...

Wanted: Advanced training for caregivers + intuitive devices

Increasingly, family caregivers with no formal training are doing the kind of work more commonly associated with hospital-based nurses: operating dialysis machines and ventilators, administering IVs and injections, and using monitors for blood glucos...

Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results

NEW YORK, May 6, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Wednesday, May 8, 2013 at 8:30 a.m. EDT to discuss results for the first quarter e...

Cantel Medical To Present At The Bank Of America Merrill Lynch Health Care Conference

LITTLE FALLS, N.J., May 6, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV at Encore at the Wynn. The formal presentation is scheduled for Thursday, May 16, 2013 at 12:00 PM PT with a Q & A session immediately following the pre...

Mortality Greatly Reduced for Pediatric Dialysis Patients

In the past 20 years, there have been dramatically fewer deaths in children with end-stage kidney disease; researchers are trying to understand why. Medscape Medical News

Trevi Therapeutics Commences Clinical Study of Nalbuphine ER

Phase 1 Study in End-Stage Renal Disease Patients on Hemodialysis Trevi Therapeutics, Inc. (“Trevi”) a drug development company focused on developing Nalbuphine ER for chronic pruritus, announced today that it has commenced a Phase 1, open-label study to characterize and compare the pharmacokinetics, safety and to

Diaverum appoints Head of Quality & Business Processes

Organisational changes centralise quality measures and create additional synergies across the countries Diaverum, one of the world’s leading renal care providers, is aligning its organisational structure to respond to the strong growth of the company. Beatriz Bottner has joined Diaverum as Chief Quality & Business Processes Officer. She is a memb...

Kidney Disease In Canada: 12.5% Of Adults Afflicted, Yet Many Unaware

An estimated 12.5% of Canadians in Canada have evidence of chronic kidney disease, including people without risk factors such as high blood pressure and diabetes, according to a study published in CMAJ (Canadian Medical Association Journal). Chronic...

Dialysis Equipment & Services Market: U.S., UK, Italy, China, Japan, India, Australia & Canada Analyzed in New Research Report at ReportsnReports.com

Dallas, Texas (PRWEB) May 06, 2013 This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medic...

Rockwell Medical to Present ESA-Sparing PRIME Study Data at 50th ERA-EDTA Congress, Istanbul 2013

WIXOM, MI -- (Marketwired) -- 05/06/13 -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that clinical data for its late-stage investigational drug Soluble Ferric Pyrophosphate (SFP) has been accepted for...

Death Rate Dropping for Children on Dialysis: Study

SATURDAY, May 4 (HealthDay News) -- The death risk for American children and teens undergoing dialysis for kidney failure has dropped significantly in recent decades, a new study finds. Researchers analyzed data from more than 23,000 patients younge...

Superstorm Sandy Recovery Continues as Patients Return to South Nassau Communities Hospital's Dialysis Center

Oceanside, NY, May 05, 2013 --(PR.com)-- Within hours after Superstorm Sandy swept over Long Island on October 29, 2012, leaving a massive trail of destruction in its wake, South Nassau Communities Hospital took immediate and decisive action to begin the process of re-opening the doors of its Outpatient Dialysis Center (OPD) to the patients who rely on it to serve as their “home away from h...

Study finds decrease in mortality rates among children initiating ESKD treatment with dialysis

In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage kidney disease treatment with dialysis between 1990 and 2010, a...

Survival Improving for Kids on Dialysis (CME/CE)

WASHINGTON (MedPage Today) -- Overall survival among children with end-stage renal disease who are being treated with dialysis has greatly improved over the last 20 years, researchers said here.

Risk of death has decreased substantially for children initially treated with dialysis for end-stage kidney disease

In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage kidney disease treatment with dialysis between 1990 and 2010, a...

GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) May 04, 2013 GranuFlo lawsuits filed in the wake of last year’s recall for GranuFlo and NaturaLyte dialysis concentrates continue to mount in state and federal courts throughout the country, Bernstein Liebhard LLP...

Risk of death has decreased for children initially treated with dialysis for ESKD

(The JAMA Network Journals) In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage kidney disease treatment with dialy...

Rockwell Medical Schedules 1st Quarter 2013 Investor Conference Call

WIXOM, MI -- (Marketwired) -- 05/03/13 -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today that it will hold its quarterly conference call to discuss...

U.S. District Court Dismisses Case Against DaVita

DaVita HealthCare Partners Inc. (NYSE: DVA) today announced that a U.S. District Court has dismissed a civil complaint filed in 2011 against DaVita® in the U.S. District Court for the Eastern District of Michigan. The company previously reported in its 2013 annual report Form 10-K that it was served with the civil complaint in January of this yea...

No Mortality Benefit Seen for Dialysis Drug (CME/CE)

(MedPage Today) -- The routine use of the calcimimetic agent cinacalcet (Sensipar) conferred little mortality benefit in patients with severe chronic kidney disease and is commonly associated with side effects, a meta-analysis confirmed.

Multimedia Now Available: Raptor Pharmaceutical's PROCYSBI(TM) Receives FDA Approval for the Treatment of Nephropathic Cystinosis

NOVATO, Calif., May 1, 2013 /PRNewswire/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced that the U.S. Food and Drug Administration (FDA) has approved PROCYSBI™ (cysteamine bitartrate) delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older. In a Phase 3 study, PROCYSBI showed consistent cystine...

Baron and Budd Now Handling Granuflo Recall Lawsuits

Alert: Granuflo Has Been Linked to Serious Health Issues, Including Heart Attack, Stroke and Cardiopulmonary Arrest Baron and Budd, a nationally recognized plaintiffs’ law firm, is now handling lawsuits related to the Granuflo recall. Granuflo is the brand name of a dialysate used in dialysis, a long-term medical treatment used to treat kidney...